The Business First of Columbus news publication reported that Ohio was ranked No. 11 in biopharmaceutical venture capital funding in an October study by the Milken Institute.  The study noted Ohio’s Third Frontier Project, a 10-year plan to spur the state’s high-tech economy, for increasing money spent on biotech.  Massachusetts ranked No. 1 in the overall ranking, with Wyoming bringing coming in last.

  Print This Post Print This Post  

Comments are closed.